Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Nature as therapy? a new trial tests outdoor outings for anxious kids

NCT ID NCT05973123

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled This study
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Aug 14, 2026 · Last updated Aug 14, 2026

Summary

This trial tests whether spending time in nature can reduce anxiety in children aged 9-12 who have experienced adverse childhood events. Participants are assigned to either group nature outings, family outings, or a waitlist. The goal is to see if these nature-based activities improve anxiety and resilience.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Nature-based group outings and family outings
What this could lead to
If effective, this could offer a low-cost, scalable way to reduce anxiety in children with a history of adverse childhood experiences.
What could go wrong
This is an early, small trial. The intervention may not outperform a waitlist control, and results may not generalize beyond this specific group.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Expected to start

Jul 2023

An estimate. Start dates often move.

Expected to finish

Sep 2023

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

9 to 12 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Pediatric Inclusion Criteria: 1. Age 9-12 years at enrollment 2. Has an ACE Score of 1 or higher 3. Has a SCARED-P score of 15 or higher 4. Is available to attend three group outings if assigned to group intervention arm. 5. Has a caregiver who is able to consent and attend outings with them. 6. Is able to read, write, and speak English, Spanish or Arabic. 7. Has no serious health conditions that affect their ability to be in nature. 8. Willing to wear a provided electronic sensor continuously for 6 weeks, including sleep, excluding bathing and device recharging time. 9. Have no major changes in their mental health treatment plan during the time of the study. Caregiver eligibility criteria 1. Able to read, write and speak English, Spanish or Arabic 2. Be at least 18 years old. 3. Have no serious health conditions that affect their ability to be in nature. 4. Is available to attend 6 weekly outings if assigned to group intervention arm. 5. Have a smart phone and be willing to download NatureDose app from NatureQuant. Exclusion Criteria Child: 1. Concomitant active treatment modification (eg medication changes) for the past month. 2. Unable to attend weekly nature outings if randomized to the group intervention. 3. Physical or health limitation to participating in outdoor activities. 4. Previous SHINE participant. 5. Caregiver unable to consent. 6. Unable to pass short quiz at the end of the assent. 7. Wards of the state who do not have a guardian other than the state who can consent on their behalf. 8. Non-English, Arabic or Spanish speaking participants. 9. Unwilling to use a FitBit. Exclusion criteria - caregiver 1. Unable to attend weekly nature outings if randomized to the group intervention. 2. Physical or health limitation to participating in outdoor activities. 3. Previous SHINE participant. 4. Unable to provide informed consent. 5. Non-English, Arabic or Spanish speaking participants. 6. Unwilling to use NatureDose app.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Adverse childhood experiences are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • UCSF Benioff Children's Hospitals

    Oakland, California, 94609, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.